Charu Aggarwal

Charu Aggarwal is the Leslye M. Heisler Professor for Lung Cancer Excellence and Section Chief of Thoracic and Head & Neck Medical Oncology at the Abramson Cancer Center, University of Pennsylvania. She is a thoracic oncologist known for plasma next-generation sequencing studies showing that adding blood-based testing to tissue testing finds more targetable lung cancer mutations, work that changed how metastatic lung cancer is genotyped. Her selected paper reports the clinical implications of plasma-based genotyping for delivering personalised therapy in metastatic non-small-cell lung cancer. She now leads immunotherapy and head and neck cancer trials at Penn.